We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Alphapharm Concedes To Forest Labs In Antidepressant Battle

Law360 (October 6, 2005, 12:00 AM EDT) -- Generic drug maker Alphapharm Pty Ltd. must steer clear of blockbuster antidepressant Lexapro for now as part its settlement agreement with Forest Laboratories Inc., ending litigation launched in May 2004.

Alphapharm, part of the generics division of Germany-based Merck KGaA, was sued by New York-based Forest and its Danish licensing partner H. Lundbeck A/S in U.S. District Court for the Southern District of New York. The case was transferred four months later to Delaware.

The settlement relieves Forest of a challenge that threatened its most lucrative...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.